Government ❯ Politics ❯ Health Policy

Drug Regulation

Fentanilo Contaminado FDA FDA Leadership FDA Actions Cost of Medications Consumer Protection Advertising Policies COVID-19 Vaccines Political Influence FDA Approval Drug Safety Pharmaceutical Industry Relations Mifepristone Safety Review Medicare Coverage Access to Healthcare Medicare Negotiations Lachgas and K.-o.-Tropfen Prescription Drugs FDA Commissioner Amyl Nitrite

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

The FDA describes an evidence‑driven study now in a data‑gathering phase with no projected timeline.

RFK Jr. To Announce New HHS Plan To Cut U.S. Drug Prices Today

HHS Orders FDA Review of Mifepristone Amid Debate Over Flawed Safety Study